AIM
Alerce Investment Management Portfolio holdings
AUM
$56.8M
This Quarter Return
+7.57%
1 Year Return
+31.17%
3 Year Return
+25.12%
5 Year Return
–
10 Year Return
–
AUM
$76.9M
AUM Growth
+$76.9M
(+1.6%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Annexon
ANNX
$226M
| $24.8M | 32.31% |
7,056,024
| – | – |
|
2
American Well
AMWL
$111M
| $22M | 28.62% |
10,475,717
| – | – |
|
3
Akebia Therapeutics
AKBA
$833M
| $14.8M | 19.29% |
16,205,119
| – | – |
|
|
WHWK
4
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $11.2M | 14.51% |
1,630,830
| – | – |
|
5
Assembly Biosciences
ASMB
$190M
| $2.56M | 3.33% |
2,227,500
| – | – |
|
|
RNTX
6
Rein Therapeutics, Inc. Common Stock
RNTX
$32M
| $1.49M | 1.93% |
830,466
| – | – |
|